News from northwest biotherapeutics, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Aug 19, 2014, 14:44 ET
Northwest Biotherapeutics Logo.  (PRNewsFoto/Northwest Biotherapeutics, Inc.)

NW BIO COMPLETES THE CLOSING OF ITS $17.5 MILLION CONVERTIBLE NOTE OFFERING

 Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid...

Aug 14, 2014, 11:47 ET
Northwest Biotherapeutics Logo.  (PRNewsFoto/Northwest Biotherapeutics, Inc.)

NW BIO ANNOUNCES PRICING OF $17.5 MILLION OFFERING OF CONVERTIBLE NOTES

Northwest Biotherapeutics, Inc. (NASDAQ: NWBO) ("NW Bio") today announced the pricing of $17.5 million aggregate principal amount of its unsecured...

Aug 13, 2014, 09:26 ET
Northwest Biotherapeutics Logo.  (PRNewsFoto/Northwest Biotherapeutics, Inc.)

NW BIO CORRECTS ONGOING FALSE CLAIMS BY FEUERSTEIN ABOUT PHASE III TRIAL OF DCVAX®-L, AND INTERIM ANALYSIS

 Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid...

Aug 11, 2014, 08:15 ET
Northwest Biotherapeutics Logo.  (PRNewsFoto/Northwest Biotherapeutics, Inc.)

NW BIO PROVIDES UPDATE ABOUT PHASE III DCVAX®-L TRIAL FOR GBM AND "INFORMATION ARM" COMPASSIONATE USE PATIENTS

 Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid...

Aug 11, 2014, 08:15 ET
Northwest Biotherapeutics Logo.  (PRNewsFoto/Northwest Biotherapeutics, Inc.)

NW BIO OBTAINS APPROVALS FOR ENHANCEMENTS OF PHASE III TRIAL OF DCVAX®-L FOR GBM BRAIN CANCER

Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor...

Jul 16, 2014, 08:15 ET
Northwest Biotherapeutics Logo.  (PRNewsFoto/Northwest Biotherapeutics, Inc.)

NW BIO ANNOUNCES COMPLETION OF DCVAX®-DIRECT PHASE I TRIAL RECRUITMENT

 Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid...

Jun 20, 2014, 08:25 ET
Northwest Biotherapeutics Logo.  (PRNewsFoto/Northwest Biotherapeutics, Inc.)

NW BIO REAFFIRMS DCVAX®-DIRECT CLINICAL TRIAL INTERIM DATA ANNOUNCEMENTS

 Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid...

Jun 16, 2014, 08:15 ET
Northwest Biotherapeutics Logo.  (PRNewsFoto/Northwest Biotherapeutics, Inc.)

NW BIO NAMED TO TWO RUSSELL INDEXES

 Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid...

Jun 11, 2014, 08:15 ET
Northwest Biotherapeutics Logo.  (PRNewsFoto/Northwest Biotherapeutics, Inc.)

DCVAX-DIRECT TRIAL UPDATE INDICATES FURTHER POSITIVE RESPONSES; 3 CASE STUDIES SHOW NO LIVE TUMOR CELLS IN INJECTED TUMORS

 Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune...

Jun 10, 2014, 08:15 ET

DCVAX®-L PHASE III TRIAL INITIATED IN GERMANY

Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor...

Jun 04, 2014, 11:23 ET
Northwest Biotherapeutics Logo.  (PRNewsFoto/Northwest Biotherapeutics, Inc.)

NW BIO TO PRESENT AT JEFFERIES 2014 GLOBAL HEALTHCARE CONFERENCE

 Northwest Biotherapeutics, Inc. (NASDAQ: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies...

May 29, 2014, 09:27 ET
Northwest Biotherapeutics Logo.  (PRNewsFoto/Northwest Biotherapeutics, Inc.)

NW BIO REFUTES MORE FALSE CLAIMS BY FEUERSTEIN

Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid...

May 27, 2014, 12:05 ET
Northwest Biotherapeutics Logo.  (PRNewsFoto/Northwest Biotherapeutics, Inc.)

NW BIO TO HOLD CONFERENCE CALL TO DISCUSS EARLY RESULTS OF DCVAX®-DIRECT ONGOING PHASE I/II TRIAL

Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio) announced today that the Company will host a conference call and webcast with CEO Linda...

May 27, 2014, 08:30 ET
Northwest Biotherapeutics Logo.  (PRNewsFoto/Northwest Biotherapeutics, Inc.)

EARLY POSITIVE RESPONSES SEEN IN OVER 50% OF DCVAX®-DIRECT PATIENTS TO DATE

Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor...

May 15, 2014, 08:00 ET
Northwest Biotherapeutics Logo.  (PRNewsFoto/Northwest Biotherapeutics, Inc.)

NW BIO ANNOUNCES FIRST DATA FROM ONGOING DCVAX-DIRECT TRIAL

Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor...

Apr 22, 2014, 08:15 ET
Northwest Biotherapeutics Logo.  (PRNewsFoto/Northwest Biotherapeutics, Inc.)

PRESENTATION ON NW BIO'S DCVAX-DIRECT TRIAL ANNOUNCED FOR ASCO ANNUAL MEETING

 Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid...

Apr 15, 2014, 13:11 ET
Northwest Biotherapeutics Logo.  (PRNewsFoto/Northwest Biotherapeutics, Inc.)

NW BIO CLOSES ON FIRST $15 MILLION OF FINANCING FOR SUBSTANTIAL EXPANSION OF EUROPEAN PRODUCTION CAPACITY

Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor...

Apr 10, 2014, 08:15 ET
Northwest Biotherapeutics Logo.  (PRNewsFoto/Northwest Biotherapeutics, Inc.)

NW BIO ANNOUNCES FINANCING OF UP TO $32 MILLION

 Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid...

Apr 07, 2014, 08:15 ET
Northwest Biotherapeutics Logo.  (PRNewsFoto/Northwest Biotherapeutics, Inc.)

NW BIO AGAIN SETS FEUERSTEIN RECORD STRAIGHT

 Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid...

Mar 28, 2014, 13:03 ET
Northwest Biotherapeutics Logo.  (PRNewsFoto/Northwest Biotherapeutics, Inc.)

NW BIO REFUTES FURTHER FALSE AND MISLEADING CLAIMS BY FEUERSTEIN

 Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid...